Average Co-Inventor Count = 3.06
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bioventrix, Inc. (7 from 55 patents)
2. Other (5 from 832,680 patents)
3. The Clorox Company (3 from 870 patents)
4. Neotract, Inc. (3 from 68 patents)
5. Vascular Access Technologies, Inc. (2 from 12 patents)
6. Bioject Inc. (1 from 40 patents)
21 patents:
1. 11051942 - Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions
2. 10925587 - Anchor delivery system
3. 10702261 - System with reloadable handle for delivering an anchor
4. 10252027 - Transvascular access device and method
5. 10179049 - Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions
6. 9937043 - Remote pericardial hemostasis for ventricular access and reconstruction or other organ therapies
7. 9877714 - System with reloadable handle for delivering an anchor
8. 9662212 - Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions
9. 9320513 - Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions
10. 9220874 - Transvascular access device and method
11. 9095363 - Remote pericardial hemostasis for ventricular access and reconstruction or other organ therapies
12. 8979750 - Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions
13. 7131961 - Needle-free injection system
14. 6270508 - End effector and instrument for endoscopic and general surgery needle control
15. D406536 - End-of-life indicator for a water treatment device